Corrigendum to “Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers”

• Aruna Korlimarla,
• PS Hari,
• Jyoti Prabhu,
• Chanthirika Ragulan,
• Yatish Patil,
• VP Snijesh,
• Krisha Desai,
• Aju Mathews,
• Sandhya Appachu,
• Ravi B. Diwakar,
• BS Srinath,
• Alan Melcher,
• Maggie Cheang,
• Anguraj Sadanandam

Affiliations

Aruna Korlimarla

St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India

PS Hari

St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, India; Division of Molecular Pathology, The Institute of Cancer Research, London, UK

Jyoti Prabhu

St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India

Chanthirika Ragulan

Division of Molecular Pathology, The Institute of Cancer Research, London, UK

Yatish Patil

Division of Molecular Pathology, The Institute of Cancer Research, London, UK

VP Snijesh

St. John's Research Institute, St. John's National Academy of Health Sciences, Bangalore, India

Krisha Desai

Division of Molecular Pathology, The Institute of Cancer Research, London, UK

Aju Mathews

MOSC Medical College, Kolenchery, Kerala, India

Sandhya Appachu

Sri Shankara Cancer Hospital and Research Centre, Bangalore, India

Ravi B. Diwakar

Sri Shankara Cancer Hospital and Research Centre, Bangalore, India

BS Srinath

Sri Shankara Cancer Hospital and Research Centre, Bangalore, India

Alan Melcher

Centre for Translational Immunotherapy, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK

Maggie Cheang

Clinical Trials and Statistical Unit, The Institute of Cancer Research, London, UK

Anguraj Sadanandam

Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Centre for Translational Immunotherapy, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Centre for Global Oncology, Division of Molecular Pathology, The Institute of Cancer Research, London, UK; Corresponding author: Anguraj Sadanandam, Ph.D., Centre for Global Oncology, Division of Molecular Pathology, The Institute of Cancer Research (ICR), 15 Cotswold Road, Sutton, SM2 5NG, United Kingdom; +0044-2034376440.